Welcome to our dedicated page for United Guardian news (Ticker: UG), a resource for investors and traders seeking the latest updates and insights on United Guardian stock.
United-Guardian, Inc. (NASDAQ: UG) is a manufacturer of cosmetic ingredients, pharmaceuticals, medical lubricants, and sexual wellness ingredients. Its news flow provides insight into how these four product categories perform over time and how external factors, such as distributor demand and supply conditions, influence reported results.
Company press releases frequently cover quarterly and annual financial results, including net sales and net income trends across cosmetic ingredients, medical lubricants, and pharmaceutical products such as Renacidin. Management commentary often explains the impact of distributor ordering patterns, particularly from Ashland Specialty Ingredients (ASI), its largest cosmetic distributor, and describes how inventory levels and demand in regions served by ASI affect cosmetic ingredient sales.
Investors can also follow dividend announcements, where United-Guardian’s Board of Directors declares cash dividends and discusses the balance between returning cash to stockholders and funding growth initiatives. These releases highlight the company’s long record of paying dividends and outline projects aimed at expanding markets for personal care products and increasing sales of Renacidin.
Additional news items may include corporate governance updates, such as board appointments, and commentary on strategic initiatives related to global marketing and distribution of cosmetic ingredients, as well as renewed emphasis on medical and pharmaceutical product sales. By reviewing the UG news feed, readers can track how United-Guardian describes the performance of its core product categories, its responses to market conditions, and the progress of projects intended to support long-term growth.
United-Guardian (NASDAQ:UG) reported a 42% rise in net income for Q3 2021, reaching $1,016,506 ($0.22 per share), compared to $717,532 ($0.16) in Q3 2020. Net sales surged by 36% to $3,179,746, up from $2,336,360. For the first nine months of 2021, net income increased by 31% to $3,542,232 ($0.77 per share), with sales climbing 19% to $10,268,592. Cosmetic ingredient sales multiplied by 187%, boosted by a 300% increase from a partner in Asia. Despite ongoing supply chain challenges, the company anticipates continued growth into 2022.
United-Guardian, Inc. (NASDAQ:UG) reported a 24% increase in Q2 sales, reaching $3,657,978 compared to $2,954,644 in 2020. Net income rose from $1,186,611 ($0.26/share) to $1,344,524 ($0.29/share). For the first half of 2021, sales increased by 13% to $7,088,846, with net income rising from $1,976,918 ($0.43/share) to $2,525,726 ($0.55/share). A significant 68% growth in cosmetic ingredient sales was noted, although future projections remain uncertain due to the pandemic.
United-Guardian, Inc. (NASDAQ:UG) has announced a cash dividend of $0.48 per share, set to be paid on June 7, 2021, to all shareholders recorded by May 31, 2021. This marks the 26th consecutive year of dividends. The decision, made during the Board of Directors meeting on May 18, 2021, reflects strong first-quarter earnings and a positive outlook for the second quarter, with a 33% increase from the prior mid-year dividend. President Ken Globus expressed confidence in the company’s financial health and anticipated market recovery.
United-Guardian, Inc. (NASDAQ: UG) reported a 49% increase in net income for Q1 2021, rising to $1,181,202 ($0.26 per share) from $790,307 ($0.17 per share) in Q1 2020. Net sales also increased by 3% to $3,430,868. The growth was driven by higher sales of cosmetic ingredients, pharmaceutical products, and medical lubricants. The company noted an improvement in distributor inventory levels compared to the previous year, which had been impacted by the pandemic.
United-Guardian, Inc. (NASDAQ:UG) reported a profitable 2020 despite pandemic challenges, with sales at $10.99 million, down from $13.60 million in 2019. Net income was $3.30 million ($0.72 per share) compared to $4.76 million ($1.04 per share) in the prior year. The pandemic notably affected cosmetic ingredient sales in China, though early 2021 signals show positive trends. Pharmaceutical sales remained strong, and the company is optimistic about future recovery and revenue growth from new products.
United-Guardian (NASDAQ:UG) declared a cash dividend of $0.36 per share, to be paid on December 8, 2020, to stockholders recorded by December 1, 2020. Despite pandemic-related challenges, the company's strong balance sheet and profitable year prompted the board's decision, though they opted to reduce the dividend due to negative impacts on sales and earnings in the second half. The company remains optimistic about strong pharmaceutical sales and potential recovery in cosmetic ingredients as global conditions improve.
United-Guardian, Inc. (NASDAQ:UG) reported a net income of $717,532 ($0.16 per share) on sales of $2,336,360 for Q3 2020, a decline from $1,069,871 ($0.23 per share) on $3,317,370 in Q3 2019. Year-to-date, net income stands at $2,694,450 ($0.59 per share) with sales of $8,613,918, compared to $3,371,375 ($0.73 per share) on $9,777,086 in the same period last year. The decline is attributed to the pandemic's impact on consumer demand, particularly in personal care products, while pharmaceutical product demand increased by 9% and 15% for the quarter and year-to-date, respectively.
United-Guardian (NASDAQ:UG) reported a 10% increase in net income for Q2 2020, reaching $1,186,611 compared to $1,078,810 in Q2 2019, despite a 10% drop in sales from $3,279,399 to $2,954,644. Year-to-date sales also declined slightly to $6,277,558 from $6,459,716 in 2019, with net income decreasing to $1,976,918 ($0.43/share) from $2,301,504 ($0.50/share). The company expects continued strength in pharmaceutical and medical product sales, although cosmetic ingredient sales may decline due to the pandemic.
United-Guardian, Inc. (NASDAQ: UG) declared a cash dividend of $0.42 per share, to be paid on June 17, 2020, to stockholders of record on June 3, 2020. This marks the 25th consecutive year of dividend payments. President Ken Globus highlighted the company’s ability to maintain production and strong sales during the Covid-19 pandemic, although he noted potential temporary declines in sales ahead. The Board expressed optimism about future performance, especially in pharmaceutical and cosmetic segments.
United-Guardian, Inc. (NASDAQ: UG) reported a 4% increase in net sales for Q1 2020, totaling $3,322,914 compared to $3,180,318 in Q1 2019. However, net income fell sharply to $790,307 ($0.17 per share) from $1,222,694 ($0.27 per share) in the prior year, primarily due to declines in marketable securities. The company maintained operations as an essential business during the pandemic, with strong sales in April. President Ken Globus noted potential future declines in cosmetic ingredient sales but expressed optimism for pharmaceuticals and medical products.